The content of lipoperoxidation products in normal and atherosclerotic human aorta

Molecular and Cellular Biochemistry

Volumn 225, Issue 1-2, 2001, Pages 21-28

  Tertov, V V ^a,b   Kaplun, V V ^a,b   Mikhailova, I A ^a,b   Suprun, I V ^a,b   Orekhov, A N ^a,b  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b Institute of Chemical Problems of Ecology   (Russian Federation)

Author keywords

Atherosclerosis; Human aorta; Lipofuscin; Lipoperoxidation; Protein bound cholesterol

Indexed keywords

CHLOROFORM; CHOLESTEROL; FLUORESCENT DYE; LIPID; LIPOFUSCIN; METHANOL; PROTEIN;

ADULT; AORTA ATHEROSCLEROSIS; AORTA INTIMA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL WALL; CLINICAL ARTICLE; CONTROLLED STUDY; COVALENT BOND; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROLYSIS; LIPID OXIDATION; LIPID PEROXIDATION; LIPID STORAGE; MALE; PROTEIN BINDING;

ADULT; AORTA; AORTIC DISEASES; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CELLS, CULTURED; CHOLESTEROL ESTERS; FEMALE; HUMANS; LIPID PEROXIDATION; LIPIDS; LIPOFUSCIN; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; TUNICA INTIMA; TUNICA MEDIA;

EID: 0034748060     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012267520932     Document Type: Article

References (37)

1. Beyond cholesterol: Modifications of low density lipoprotein that increase its atherogenicity
2. Role of oxidized low density lipoprotein in atherogenesis
3. The role of lipid peroxidation and antioxidants in oxidative modification of LDL
4. The role of oxidized lipoprotein in atherogenesis
5. Lipids in human atheroma. Part 5. The occurrence of a new group of polar sterol esters in various stages of human aorta
6. Lipids and oxidized lipids in human atherosclerotic lesions at different stages of development
7. Evidence of lipid oxidation in pulmonary artery atherosclerosis
8. Structure elucidation of oxygenated lipids in human atherosclerotic lesions
9. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques
10. Mass spectrometric quantification of markers for protein oxidation by tyrosys radical, cooper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques
11. Presence of hypochlorite-modified proteins in human atherosclerotic lesions
12. Evidence for lipid peroxidation in atherosclerosis
13. Low density lipoprotein undergoes oxidative modification in vivo
14. Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apolipoprotein(a)
15. 2-protein adducts in human plasma and vasculature
16. Oxidation products of cholesteryl linoleate are existent to hydrolysis in macrophages, form complexes with proteins, and are present in human atherosclerotic lesions
17. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo
18. What is the significance of ceroid in human atherosclerosis?
19. Composition and classification of human atherosclerotic lesions
20. Lipids in cells of atherosclerotic and uninvolved human aorta. I. Lipid composition of aortic tissue and enzyme isolated and cultured cells
21. A rapid method of total lipid extraction and purification
22. Protein measurement with the Folin phenol reagent
23. Enzymatic detoxication of superoxide anion-radicals and lipoperoxides in intima and media of atherosclerotic aorta
24. The distribution of seroid in human atherosclerosis
25. Lipid peroxidation and ceroid accumulation in macrophages cultured with oxidized low density lipoprotein
26. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells. Discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients
27. Desialylated low density lipoprotein - Naturally occurring modified lipoprotein with atherogenic potency
28. Identification of multiple subclasses of plasma low density lipoproteins in normal humans
29. Presence of a modified low density lipoprotein in humans
30. Similarity between naturally occurring modified desialylated, electronegative and aortic low density lipoprotein
31. Naturally occurring modified low density lipoproteins are similar if not identical: More electronegative and desialylated lipoprotein subfractions
32. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation: Isolation, fractionation and characterization
33. In vivo oxidized low density lipoprotein: Degree of lipoprotein oxidation does not correlate with its atherogenic properties
34. Interaction of low density lipoprotein with arterial proteoglycans: The role and charge of sialic acid content
35. Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans
36. Antioxidant content in low density lipoprotein and lipoprotein oxidation in vivo and in vitro